




Gene conversion has a central role in the evolutionary fine-tuning of
regulatory elements in the fruit fly Drosophila miranda.
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Image Beneficial mutations can spread
quickly via gene conversion to multiple
locations in a genome
N
atural selection means that an individual
with a beneficial mutation is more likely to
pass on its genes to its offspring. This
‘vertical’ process means that, eventually, the
entire population can share the same beneficial
mutation at the same location in the genome.
However, beneficial mutations can also spread
‘horizontally’ so that they are shared between
two (or more) locations in the genome of an
individual (Figure 1). There are only a few ways that
this horizontal movement can happen in animals
and other eukaryotes. One way involves genetic
parasites—called transposable elements—that
‘cut’ or ‘copy’ themselves from one location
and then ‘paste’ themselves elsewhere in the
genome. Gene conversion is another mechanism
whereby one region of DNA is copied and used
to replace a different, but highly similar, stretch
of DNA. Now, in eLife, Christopher Ellison and
Doris Bachtrog—both from the University of
California, Berkeley—report that a beneficial
mutation has spread via these two mechanisms
to multiple sites on the X chromosome of the fruit
flyDrosophila miranda (Ellison and Bachtrog, 2015).
Humans and many other animals have sex
chromosomes. Human females are XX and
human males are XY; this means that females
have two copies of every gene on the X
chromosome, but males only have one copy.
Many sex chromosomes have a so-called ‘dosage
compensation system’ to counteract this imbal-
ance, which makes sure that males and females
get an equal dose of the molecules made from
the genes on the sex chromosomes.
A dosage compensation system is not some-
thing every sex chromosome has from its
beginning. Instead, it has to be established
through the course of evolution after the sex
chromosome has formed. This process appears
to be currently ongoing in Drosophila miranda,
which developed a new X chromosome, called
neo-X, about 1.5 million years ago, and provides
an excellent opportunity to study how dosage
compensation gets established (Ellison and
Bachtrog, 2013).
In fruit flies, dosage compensation relies on
a male-specific molecular complex that binds to
a short sequence of DNA found multiple times
across the X chromosome (Conrad and Akhtar,
2011). This complex then acts to increase the
expression of nearby genes, which ensures that
males receive a full dose of the molecules made
from these genes. Thus, the most recently formed
neo-X chromosome of Drosophila miranda
needed to somehow develop sequence motifs
that can also recruit this molecular complex.
Ellison and Bachtrog previously showed that
such sequences are provided, in part, by a family
of transposable elements that had recently
copied itself across the neo-X chromosome
(Ellison and Bachtrog, 2013). In fact, the binding
motifs of the older X chromosome were also
derived from transposable elements, and nature
often seems to look to transposable elements
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when facing similar challenges. A number of
studies have shown that transposable elements
often serve as sources of ready-to-use binding
motifs that can help regulate the expression of
networks of genes (Cowley and Oakey, 2013;
Sundaram et al., 2014). However, nature does
not always get it right first time. Instead, the first
attempt can be more of a ‘quick and dirty’
solution that is subject to further improvement
over the course of evolution. Ellison and Bach-
trog had previously found that the binding
motifs derived from transposable elements on
the neo-X chromosome are suboptimal (Ellison
and Bachtrog, 2013). This led them to hypothe-
size that ‘fine-tuning’ of the process might be
going on.
Figure 1. Beneficial mutations can spread through a population both ‘vertically’ and ‘horizontally’. Consider
a hypothetical population with 10 individuals, each with a single chromosome that has four sites (open circles).
(A) When beneficial mutations (red circles) are only passed ‘vertically’ between generations, the best possible
outcome (shown in bottom dashed circle) is for all the individuals in the population to eventually have the beneficial
mutation at the site where it appeared (i.e., the leftmost of the four circles). (B) However, when horizontal events
(blue arrows) are involved, it is possible that an individual (marked with a star) can have the beneficial mutation at all
four sites. Over time, the ‘vertical’ spread and natural selection can make it possible for all the individuals in the
population to have the beneficial mutation at all four sites (not shown). These horizontal events could be the
movement of a transposable element or, as Ellison and Bachtrog report, gene conversion.
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But, how could this fine-tuning be achieved?
We can imagine that a beneficial mutation that
allows the dosage compensation complex to
bind more strongly might occur in one copy of
the transposable element family. Would the only
solution be for this transposable element to copy
and paste itself across the neo-X again? In other
words, would the entire dosage compensation
network have to be rebuilt from scratch each
time any copy acquires a better mutation?
Fortunately, it appears that ‘no’ is the answer
to this question. Instead, nature seems to have
a far more elegant solution that involves the
spread of beneficial mutations via gene conver-
sion. Ellison and Bachtrog identified two muta-
tions in the transposable element that make it
better at recruiting the molecular complex that
carries out dosage compensation. They then
showed that these two mutations are spreading
across the different copies of the transposable
element-derived regulatory element on the neo-
X by gene conversion. Of course, gene conver-
sion can work in both directions; that is to say,
the process can spread a mutation or reverse it.
However, because the mutations found by Ellison
and Bachtrog are beneficial, natural selection
tend to favor individuals where the mutation has
spread over those where it has been reversed.
Gene conversion provides three major advan-
tages in spreading beneficial mutations. First,
mutations that are closer together, as is the case
with the two mutations identified by Ellison and
Bachtrog, can be transferred simultaneously. Sec-
ond, it allows genetic variation to migrate across
multiple sites in the genome, which, in turn, actually
makes natural selection more efficient (Mano and
Innan, 2008). Third, beneficial mutations present in
different copies, or lineages, can be brought
together. This may be analogous to the role of
sexual recombination, which is considered as one
of the major reasons why we have two sexes.
Although Ellison and Bachtrog only focused
on the two mutations in this study, other
beneficial mutations might also be present, or
might arise in the future. It is likely that the fine-
tuning of the dosage compensation system will
continue by sharing such mutations across the
entire family by gene conversion. It should be
interesting to investigate whether such fine-
tuning has occurred throughout the evolution of
other regulatory networks.
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